{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T07:52:31Z","timestamp":1768463551708,"version":"3.49.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T00:00:00Z","timestamp":1528156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12957-018-1404-8","type":"journal-article","created":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T10:31:02Z","timestamp":1528194662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Carotid artery infusion via implantable catheters for squamous cell carcinoma of the tonsils"],"prefix":"10.1186","volume":"16","author":[{"given":"Karl Reinhard","family":"Aigner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Gailhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2952-6180","authenticated-orcid":false,"given":"Kornelia","family":"Aigner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,5]]},"reference":[{"key":"1404_CR1","first-page":"487","volume-title":"Induction chemotherapy \u2013 systemic and Locoregional","author":"KR Aigner","year":"2016","unstructured":"Aigner KR, Selak E. Isolated thoracic perfusion with chemofiltration (ITP-F) for advanced and pretreated non-small-cell lung cancer. In: Aigner KR, Stephens FO, editors. Induction chemotherapy \u2013 systemic and Locoregional. Second ed. Berlin-Heidelberg: Springer-Verlag; 2016. p. 487\u201395.","edition":"Second"},{"key":"1404_CR2","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S1470-2045(07)70144-4","volume":"8","author":"A Trotti","year":"2017","unstructured":"Trotti A, Pajak TF, Gwede CK, et al. TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. Lancet Oncol. 2017;8:613\u201324.","journal-title":"Lancet Oncol"},{"key":"1404_CR3","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1200\/JCO.2015.61.4115","volume":"33","author":"J Ringash","year":"2015","unstructured":"Ringash J. Survivorship and quality of life in head and neck cancer. J Clin Oncol. 2015;33:3322\u20137.","journal-title":"J Clin Oncol"},{"key":"1404_CR4","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3322\/caac.21157","volume":"62","author":"JB Epstein","year":"2012","unstructured":"Epstein JB, Thariat J, Bensadoun RJ, et al. Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin. 2012;62:400\u201322.","journal-title":"CA Cancer J Clin"},{"key":"1404_CR5","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.1200\/JCO.2007.13.8941","volume":"26","author":"S Misono","year":"2008","unstructured":"Misono S, Weiss NS, Fann JR, et al. Incidence of suicide in persons with cancer. J Clin Oncol. 2008;26:4731\u20138.","journal-title":"J Clin Oncol"},{"key":"1404_CR6","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1200\/JCO.2015.65.4673","volume":"34","author":"N Osazuwa-Peters","year":"2016","unstructured":"Osazuwa-Peters N, Boakye EA, Walker RJ, et al. Suicide: a major threat to head and neck cancer survivorship. J Clin Oncol. 2016;34:1151.","journal-title":"J Clin Oncol"},{"key":"1404_CR7","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1200\/JCO.2016.68.3300","volume":"35","author":"S Marur","year":"2016","unstructured":"Marur S, Li S, Cmelak AJ, et al. E1308: phase II trial of induction chemotherapy followed by reduced-dose radiation and weekly cetuximab in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx\u2014ECOG-ACRIN Cancer Research Group. J Clin Oncol. 2016;35:490\u20137.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1404_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ijrobp.2010.10.041","volume":"82","author":"J Setton","year":"2012","unstructured":"Setton J, Caria N, Romanyshyn J, et al. Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys. 2012;82(1):291\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1404_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0360-3016(97)00092-8","volume":"38","author":"KT Robbins","year":"1997","unstructured":"Robbins KT, Kumar P, Regine WF, et al. Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. Int J Radiat Oncol Biol Phys. 1997;38:263\u201371.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1404_CR10","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1200\/JCO.2005.03.168","volume":"23","author":"KT Robbins","year":"2005","unstructured":"Robbins KT, Kumar P, Harris J, et al. Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615. J Clin Oncol. 2005;23:1447\u201354.","journal-title":"J Clin Oncol"},{"key":"1404_CR11","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1200\/JCO.1994.12.10.2113","volume":"12","author":"KT Robbins","year":"1994","unstructured":"Robbins KT, Storniolo AM, Kerber C, et al. Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer. J Clin Oncol. 1994;12:2113\u201320.","journal-title":"J Clin Oncol"},{"key":"1404_CR12","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1002\/cncr.25234","volume":"116","author":"CR Rasch","year":"2010","unstructured":"Rasch CR, Hauptmann M, Schornagel J, et al. Intra-arterial versus intravenous chemoradiation for advanced head and neck cancer: results of a randomized phase 3 trial. Cancer. 2010;116:2159\u201365.","journal-title":"Cancer"},{"key":"1404_CR13","first-page":"74","volume":"6","author":"K Aigner","year":"1983","unstructured":"Aigner K, Tonn JC, Hechtel R, et al. Die intraarterielle Zytostatikatherapie mit ven\u00f6ser Filtration im halboffenen System. Onkologie. 1983;6:74\u20136.","journal-title":"Onkologie"},{"key":"1404_CR14","first-page":"123","volume-title":"Induction chemotherapy\u2014systemic and locoregional","author":"KR Aigner","year":"2016","unstructured":"Aigner KR, Selak E, Schlaf R. Isolated thoracic perfusion with carotid artery infusion for advanced and chemoresistant tumors of the parotid gland and tonsils. In: Aigner KR, Stephens FO, editors. Induction chemotherapy\u2014systemic and locoregional. Second ed. Berlin-Heidelberg: Springer-Verlag; 2016. p. 123\u201330.","edition":"Second"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-018-1404-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12957-018-1404-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-018-1404-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T19:09:21Z","timestamp":1559675361000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-018-1404-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,5]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1404"],"URL":"https:\/\/doi.org\/10.1186\/s12957-018-1404-8","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,5]]},"assertion":[{"value":"23 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The investigations were performed in compliance with the principles of good clinical practice outlined in the Declaration of Helsinki and federal guidelines, and approval from the Medias Institutional Review Committee was acquired. Informed consent was obtained from each participant or the participant\u2019s guardian.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from every individual whose data are included in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"104"}}